ACLS Provider: Course

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. Atropine is given at 0.5 mg IV every 3-5 minutes for unstable bradycardia caused by vagal stimulation or primary AV block.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.

Incorrect. The target oxygen saturation is 92-96% to avoid hyperoxia, which can contribute to oxidative injury.

Incorrect. Rhythm checks are performed every 2 minutes to evaluate for shockable rhythms and assess the need for defibrillation.

Incorrect. Minimizes interruptions to maintain blood flow to vital organs.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. Providing 6-8 breaths per minute ensures adequate oxygenation and ventilation without interfering with chest compressions.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. The most reliable method to confirm and monitor placement by measuring exhaled CO?.

Incorrect. IV access is preferred for rapid administration; IO is the alternative if IV access is unavailable.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. Adenosine is administered as a rapid IV push at an initial dose of 6 mg to terminate stable SVT.

Incorrect. Targeted temperature management improves neurological outcomes by preventing further brain injury.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation without risking incomplete recoil or excessive fatigue.

Incorrect. Amiodarone is used to stabilize wide-complex tachycardias in stable patients to prevent deterioration into cardiac arrest.

Incorrect. Waveform capnography ensures proper ET tube placement by continuously monitoring exhaled CO? levels.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and must be corrected to restore spontaneous circulation.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Hypokalemia can cause cardiac arrhythmias and is included in the "H's" of reversible causes of cardiac arrest.

Incorrect. Epinephrine at 1 mg IV every 3-5 minutes is used to enhance perfusion during cardiac arrest.

Incorrect. Compressing 2-2.4 inches ensures effective perfusion during adult CPR while minimizing the risk of injury.

Incorrect. Pulseless VT is a shockable rhythm that requires immediate defibrillation to restore a perfusing rhythm.

Incorrect. Immediate defibrillation is critical for shockable rhythms like ventricular fibrillation and pulseless VT.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation in adults during CPR without an advanced airway.

Incorrect. The recommended rate for chest compressions is 100-120 compressions per minute to maximize perfusion.

Incorrect. TTM is used to reduce neurological injury post-ROSC by maintaining a core temperature of 32-36°C.

Incorrect. Atropine is given at a dose of 0.5 mg every 3-5 minutes during bradycardia, up to a maximum dose of 3 mg.

Incorrect. If VF persists after defibrillation and epinephrine, amiodarone is administered to stabilize the rhythm.

Incorrect. Pulse checks during CPR should not exceed 10 seconds to minimize interruptions in chest compressions.

Incorrect. Epinephrine is the first-line drug for VF, with amiodarone as the preferred antiarrhythmic for refractory cases.

Incorrect. A compression fraction greater than 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be completed before checking the rhythm.

Incorrect. Early defibrillation is critical for survival, especially in shockable rhythms like VF/VT.

Incorrect. Immediate defibrillation is the most effective intervention for a witnessed cardiac arrest in VF.

Incorrect. Switching compressors every 2 minutes reduces rescuer fatigue, ensuring high-quality chest compressions are maintained.

Incorrect. Epinephrine is administered to increase coronary and cerebral perfusion pressure during cardiac arrest.

Incorrect. Placing hands on the lower half of the sternum ensures effective chest compressions without damaging other structures.

Incorrect. Synchronized cardioversion restores organized cardiac activity in unstable atrial flutter.

Incorrect. A PETCO2 level greater than 10 mmHg indicates that chest compressions are generating adequate blood flow.

Incorrect. Ventricular fibrillation is the most common cause of sudden cardiac arrest and requires immediate defibrillation.

Incorrect. Hypoxia is a reversible cause of PEA; it must be treated immediately with oxygenation and ventilation.

Incorrect. Providing 6-8 breaths per minute prevents hyperventilation and maintains adequate oxygenation during CPR with an advanced airway.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. A compression fraction above 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. CPR should be resumed immediately after defibrillation to maintain perfusion and increase the likelihood of ROSC.

Incorrect. Reduces the risk of oxidative stress and worsened outcomes by preventing hyperoxia.

Incorrect. Symptomatic second-degree AV block type II can progress to complete heart block, requiring pacing.

Incorrect. PETCO2 levels greater than 10 mmHg suggest that chest compressions are generating adequate circulation.

Incorrect. The maximum dose of atropine for bradycardia is 3 mg, with doses given at 0.5 mg intervals every 3-5 minutes.

Incorrect. Synchronized cardioversion is indicated for unstable atrial fibrillation to restore sinus rhythm and prevent hemodynamic collapse.

Incorrect. Maximum energy for monophasic defibrillators; for biphasic, follow manufacturer recommendations.

Incorrect. Epinephrine is administered every 3-5 minutes during cardiac arrest to maximize coronary and cerebral perfusion.

Incorrect. TTM helps reduce neurological injury by maintaining a core temperature of 32-36°C after the return of spontaneous circulation.

Incorrect. Stabilizes the myocardium and suppresses arrhythmias during refractory VF or pulseless VT.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Synchronized cardioversion is used to terminate unstable SVT by restoring normal electrical activity in the heart.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.